A Molecular Revolution Is Underway in Thoracic Oncology
June 20th 2022Targetable alterations including BRAF V600E, EGFR exon 20 insertions, KRAS G12C mutations, MET exon 14 alterations, NTRK and RET rearrangements have taken up recent focus for investigators as data are pushing novel agents through the regulatory processes.
Adjuvant and Neoadjuvant Treatments Chart New Course in Advanced RCC
June 17th 2022A panel of kidney cancer experts discuss how therapeutic strategies in the neoadjuvant and adjuvant settings are affecting outcomes and how treatment selection in the first line has shifted approaches in the second and later lines of therapy.
Efforts Are Needed to Address the Enigmatic Rise of Young-Onset Gastrointestinal Cancers
June 16th 2022Despite a steady decline in incidence and mortality rates of many cancers among older individuals in the United States and other high-income countries, an alarming rise in young-onset gastrointestinal cancers has simultaneously occurred.